Satellos Bioscience Inc. (MSCL)
TSX
13.29
-0.22 (-1.63%)
Closed
Aug 24, 2026
Day's Range
13.0013.52
52 wk Range
7.0818.98
Financial Statements - MSCL - Satellos Bioscience Inc.
Revenue
0
Net Income
-24.87M▼ 27.0%
EBITDA
-26.85M▼ 45.9%
Free Cash Flow
-23.60M▼ 35.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | 119.91K | 48.16K |
| Gross Profit | - | - | - | - | -119.91K | -48.16K |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -26.45M | -19.37M | -15.46M | -8.42M | -4.70M | -1.47M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 398K | -1.15M | -1.58M | -2.95M | -9.82M | -85.24K |
| Pre Tax Income | -24.70M | -19.57M | -15.88M | -11.31M | -15.50M | -1.57M |
| Income Tax | 172K | 0 | 0 | 5K | 0 | - |
| Net Income | -24.87M | -19.57M | -15.88M | -11.32M | -15.50M | -1.57M |
| EPS Basic | -1.700004 | 2.090316 | -0.18 | -0.32 | -0.64 | -0.048028 |
| EPS Diluted | -1.700004 | 2.090316 | -0.18 | -0.32 | -0.64 | -0.048028 |
| Basic Shares Outstanding | 14.59M | 13.32M | 86.40M | 35.68M | 24.07M | 32.86M |
| Diluted Shares Outstanding | 14.59M | 13.32M | 86.40M | 35.68M | 24.07M | 32.86M |
| Ebit | -26.45M | -19.57M | -15.71M | -11.31M | -14.52M | -1.55M |
| Ebitda | -26.85M | -18.40M | -14.12M | -8.02M | -4.57M | -1.54M |
| Net Income Continuous Operations | -24.87M | -19.57M | -15.88M | -11.32M | -15.50M | -1.57M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
